Our commitment to hepatitis C elimination around the world
We are working with the hepatitis C community to support an estimated 300 micro-elimination projects across the globe. These targeted, local initiatives are helping move us closer to a world free of hepatitis C.
Our micro-elimination projects are helping to fuel new models of care from the prisons of Portugal to the remote mountains of South Korea. These selected efforts are a preview of AbbVie projects being conducted around the world aimed at helping eliminate hepatitis C (HCV)—with more to come:
The World Health Organization's 2030 goal to eliminate hepatitis C is only 11 years away. We all have a part to play. Learn more about how we’re moving fast and working hard to help eliminate hepatitis C.
We all have a part to play in making hepatitis C elimination the next public health success story, and transformative partnerships are essential to helping solve some of the most pressing challenges. Hear what some of AbbVie’s partners in eliminating hepatitis C have to say about it.
Removing barriers to care
Addressing barriers to hepatitis C care will mean uniting all of us — healthcare providers, patients, advocates, caregivers, healthcare systems — in a collective effort to overcome the obstacles. Hear how lack of education, stigma, and discrimination can prevent people affected by hepatitis C from accessing care.
Partnering to solve pressing challenges
We have a long history of working with stakeholders to increase access to our medicines worldwide, including licensing our medicine to quality-assured providers of generics so treatments are available for individuals in more than 90 low- and middle-income countries and territories.